Table 1 Correlations between PIK3R1 expression and clinicopathologic characteristics in HCC cancer
From: Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
Clinicopathologic Characteristics | No. of patients | PIK3R1 | p value | |
|---|---|---|---|---|
High | Low | |||
Age (year) | ||||
> 60 | 63 | 34 (54.0%) | 29 (46.0%) | 0.548 |
≤ 60 | 29 | 16 (55.2%) | 13 (44.8%) | |
Gender | ||||
Male | 57 | 26 (45.6%) | 31 (54.4%) | 0.484 |
Female | 35 | 15 (42.9%) | 20 (57.1%) | |
Tumor size (cm) | ||||
< 3 | 38 | 21 (55.3%) | 17 (44.7%) | 0.503 |
≥ 3 | 54 | 31 (57.4%) | 23 (42.6%) | |
Lymphatic metastasis | ||||
N0 | 59 | 24 (40.7%) | 35 (59.3%) | 0.029* |
N1–N4 | 33 | 21 (63.6%) | 12 (36.4%) | |
Distal metastasis | ||||
M0 | 79 | 21 (26.6%) | 58 (73.4%) | 0.004** |
M1 | 13 | 9 (69.2%) | 4 (30.8%) | |
TNM stage | ||||
0 & I & II | 64 | 19 (29.7%) | 45 (70.3%) | 0.002** |
III & IV | 28 | 18 (64.3%) | 10 (35.7%) | |